Alexander Monto

Summary

Country: USA

Publications

  1. ncbi Steatosis in chronic hepatitis C: relative contributions of obesity, diabetes mellitus, and alcohol
    Alexander Monto
    Department of Veterans Affairs Medical Center, University of California, San Francisco, San Francisco, CA 94121, USA
    Hepatology 36:729-36. 2002
  2. ncbi Risks of a range of alcohol intake on hepatitis C-related fibrosis
    Alexander Monto
    Department of Gastroenterology, University of California at San Francisco, 4150 Clement Street 111B, San Francisco, CA 94121, USA
    Hepatology 39:826-34. 2004
  3. ncbi Hepatic steatosis in HIV/hepatitis C coinfection: prevalence and significance compared with hepatitis C monoinfection
    Alexander Monto
    Gastroenterology Section, Veterans Affairs Medical Center, University of California, 4150 Clement Street 111B, San Francisco, CA 94121, USA
    Hepatology 42:310-6. 2005
  4. ncbi Contributions to hepatic fibrosis in HIV-HCV coinfected and HCV monoinfected patients
    Alexander Monto
    Gastroenterology Section, Veterans Affairs Medical Center, San Francisco, California 94121, USA
    Am J Gastroenterol 101:1509-15. 2006
  5. ncbi Retreatment of hepatitis C with consensus interferon and ribavirin after nonresponse or relapse to pegylated interferon and ribavirin: a national VA clinical practice study
    Helen S Yee
    Gastroenterology Section, Department of Veterans Affairs Medical Center VAMC, 4150 Clement Street 111B, San Francisco, CA 94121, USA
    Dig Dis Sci 56:2439-48. 2011
  6. ncbi Lessons from HIV therapy applied to viral hepatitis therapy: summary of a workshop
    Alexander Monto
    Department of Medicine, San Francisco Veterans Affairs Medical Center, San Francisco, California 94121, USA
    Am J Gastroenterol 105:989-1004; quiz 988, 1005. 2010
  7. ncbi Non-Markov multistate modeling using time-varying covariates, with application to progression of liver fibrosis due to hepatitis C following liver transplant
    Peter Bacchetti
    University of California, San Francisco, CA, USA
    Int J Biostat 6:Article 7. 2010
  8. ncbi Management and treatment of patients with cirrhosis and portal hypertension: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program
    Guadalupe Garcia-Tsao
    Department of Veterans Affairs Medical Center, West Haven, Connecticut, USA
    Am J Gastroenterol 104:1802-29. 2009
  9. ncbi Monocyte activation in HIV/HCV coinfection correlates with cognitive impairment
    Hans Rempel
    Department of Laboratory Medicine, Veterans Affairs Medical Center, San Francisco, California, USA
    PLoS ONE 8:e55776. 2013
  10. ncbi Hepatocellular carcinoma after sustained virologic response in hepatitis C patients without cirrhosis on a pretreatment liver biopsy
    Justin L Sewell
    Gastroenterology Section, University of California San Francisco, San Francisco, California 94143, USA
    Eur J Gastroenterol Hepatol 21:225-9. 2009

Detail Information

Publications18

  1. ncbi Steatosis in chronic hepatitis C: relative contributions of obesity, diabetes mellitus, and alcohol
    Alexander Monto
    Department of Veterans Affairs Medical Center, University of California, San Francisco, San Francisco, CA 94121, USA
    Hepatology 36:729-36. 2002
    ..Significant alcohol or NASH injury was found in only 6% of biopsy specimens. In conclusion, steatosis in HCV infection is associated with risk factors for NASH, particularly obesity, rather than alcohol consumption...
  2. ncbi Risks of a range of alcohol intake on hepatitis C-related fibrosis
    Alexander Monto
    Department of Gastroenterology, University of California at San Francisco, 4150 Clement Street 111B, San Francisco, CA 94121, USA
    Hepatology 39:826-34. 2004
    ..Age, serum ALT, and inflammation are independently associated with fibrosis in multivariate analysis, highlighting the fact that variables other than alcohol intake predominate in the production of hepatic fibrosis...
  3. ncbi Hepatic steatosis in HIV/hepatitis C coinfection: prevalence and significance compared with hepatitis C monoinfection
    Alexander Monto
    Gastroenterology Section, Veterans Affairs Medical Center, University of California, 4150 Clement Street 111B, San Francisco, CA 94121, USA
    Hepatology 42:310-6. 2005
    ..In conclusion, steatosis is less common in HIV/HCV coinfected patients than similar HCV monoinfected patients, and predictors of steatosis differ between the two groups...
  4. ncbi Contributions to hepatic fibrosis in HIV-HCV coinfected and HCV monoinfected patients
    Alexander Monto
    Gastroenterology Section, Veterans Affairs Medical Center, San Francisco, California 94121, USA
    Am J Gastroenterol 101:1509-15. 2006
    ..Immune compromise plays an important role in liver disease in coinfected patients, and the role of other clinical factors in liver disease may differ between these two groups, as well...
  5. ncbi Retreatment of hepatitis C with consensus interferon and ribavirin after nonresponse or relapse to pegylated interferon and ribavirin: a national VA clinical practice study
    Helen S Yee
    Gastroenterology Section, Department of Veterans Affairs Medical Center VAMC, 4150 Clement Street 111B, San Francisco, CA 94121, USA
    Dig Dis Sci 56:2439-48. 2011
    ..As such, CIFN/RBV use and efficacy in clinical practice were evaluated within the Department of Veterans Affairs (VA), the largest national, integrated system for HCV care...
  6. ncbi Lessons from HIV therapy applied to viral hepatitis therapy: summary of a workshop
    Alexander Monto
    Department of Medicine, San Francisco Veterans Affairs Medical Center, San Francisco, California 94121, USA
    Am J Gastroenterol 105:989-1004; quiz 988, 1005. 2010
    ..This article summarizes that conference...
  7. ncbi Non-Markov multistate modeling using time-varying covariates, with application to progression of liver fibrosis due to hepatitis C following liver transplant
    Peter Bacchetti
    University of California, San Francisco, CA, USA
    Int J Biostat 6:Article 7. 2010
    ....
  8. ncbi Management and treatment of patients with cirrhosis and portal hypertension: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program
    Guadalupe Garcia-Tsao
    Department of Veterans Affairs Medical Center, West Haven, Connecticut, USA
    Am J Gastroenterol 104:1802-29. 2009
    ..A rational management of cirrhosis will result in improvements in quality of life, treatment adherence, and, ultimately, in outcomes...
  9. ncbi Monocyte activation in HIV/HCV coinfection correlates with cognitive impairment
    Hans Rempel
    Department of Laboratory Medicine, Veterans Affairs Medical Center, San Francisco, California, USA
    PLoS ONE 8:e55776. 2013
    ..HIV-suppressed coinfected subjects with controlled HIV viral load experiencing immune activation could benefit significantly from successful anti-HCV therapy and may be considered as preferential candidates...
  10. ncbi Hepatocellular carcinoma after sustained virologic response in hepatitis C patients without cirrhosis on a pretreatment liver biopsy
    Justin L Sewell
    Gastroenterology Section, University of California San Francisco, San Francisco, California 94143, USA
    Eur J Gastroenterol Hepatol 21:225-9. 2009
    ..As fibrosis may advance, and because SVR and lack of cirrhosis do not fully protect against HCC, future study should further evaluate the risk of HCC among hepatitis C patients after sustained virologic response...
  11. ncbi Liver disease in injection drug users with hepatitis C, with and without HIV coinfection
    Alexander Monto
    San Francisco Veterans Affairs Medical Center, CA, USA
    J Addict Dis 27:49-59. 2008
    ..Limiting liver disease progression in IDUs with hepatitis C may well be best accomplished through promoting their full utilization of health care...
  12. ncbi A prospective study to examine persistent HCV reinfection in injection drug users who have previously cleared the virus
    Sue L Currie
    Department of Medicine, University of California San Francisco, San Francisco, CA 94121, USA
    Drug Alcohol Depend 93:148-54. 2008
    ..Many HCV-infected persons with recent or ongoing injection drug use (IDU) do not receive HCV treatment due to the perceived risk of HCV reinfection. There are few prospective studies investigating HCV reinfection among IDUs...
  13. ncbi Differential cognitive impairment in HCV coinfected men with controlled HIV compared to HCV monoinfection
    Bing Sun
    Department of Laboratory Medicine, Veterans Affairs Medical Center, San Francisco, CA 94121, USA
    J Acquir Immune Defic Syndr 62:190-6. 2013
    ....
  14. ncbi Periprocedural complications by Child-Pugh class in patients undergoing transcatheter arterial embolization or chemoembolization to treat unresectable hepatocellular carcinoma at a VA medical center
    Jeffery S Russell
    Department of Medicine, University of California, San Francisco, Medical Center, USA
    Am J Surg 200:659-64. 2010
    ..The aim of this study was to compare periprocedural complications in a population with hepatitis C virus-related hepatocellular carcinoma to evaluate for differences in complications by severity of liver disease...
  15. ncbi The human fetal immune response to hepatitis C virus exposure in utero
    Jennifer M Babik
    Division of Experimental Medicine, Department of Medicine, University of California, San Francisco, CA 94143 1234, USA
    J Infect Dis 203:196-206. 2011
    ..Although the rate of mother-to-child transmission of hepatitis C virus (HCV) is low, the effect of HCV exposure in utero on the fetal immune system is unknown...
  16. ncbi Role of retroviral restriction factors in the interferon-α-mediated suppression of HIV-1 in vivo
    Satish K Pillai
    Department of Medicine, University of California, San Francisco, CA 94143, USA
    Proc Natl Acad Sci U S A 109:3035-40. 2012
    ....
  17. ncbi Identification of two gene variants associated with risk of advanced fibrosis in patients with chronic hepatitis C
    Hongjin Huang
    Celera Diagnostics, Alameda, California, USA
    Gastroenterology 130:1679-87. 2006
    ..The aim of this study was to identify genetic polymorphisms that can predict the risk of advanced fibrosis in patients with CHC...
  18. ncbi Fibrosis progression in chronic hepatitis C patients with occult hepatitis B co-infection
    Chee Kin Hui
    Department of Medicine, The University of Hong Kong, Hong Kong SAR, China
    J Clin Virol 35:185-92. 2006
    ..946). In conclusion, chronic HCV patients with occult HBV co-infection does not seem to progress more than patients without occult HBV infection. However, more large-scale studies are needed before a definite conclusion can be obtained...